Regeneron Pharmaceuticals
REGN
#288
Rank
NZ$131.56 B
Marketcap
NZ$1,241
Share price
-0.61%
Change (1 day)
-7.63%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$53.49 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company has NZ$53.49 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Regeneron Pharmaceuticals - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$52.04 B26.73%
2023-12-31$NZ$41.07 B15.05%
2022-12-31$NZ$35.69 B29.91%
2021-12-31$NZ$27.47 B79.83%
2020-12-31$NZ$15.28 B-7.2%
2019-12-31$NZ$16.46 B26.12%
2018-12-31$NZ$13.05 B50.91%
2017-12-31$NZ$8.65 B34.69%
2016-12-31$NZ$6.42 B20.28%
2015-12-31$NZ$5.34 B64.06%
2014-12-31$NZ$3.25 B37.02%
2013-12-31$NZ$2.37 B56.91%
2012-12-31$NZ$1.51 B143.25%
2011-12-31$NZ$0.62 B-9.03%
2010-12-31$NZ$0.68 B25.24%
2009-12-31$NZ$0.54 B-24.79%
2008-12-31$NZ$0.72 B20.88%
2007-12-31$NZ$0.60 B95.42%
2006-12-31$NZ$0.30 B84.35%
2005-12-31$NZ$0.16 B-34.8%
2004-12-31$NZ$0.25 B20.82%
2003-12-31$NZ$0.21 B-24.09%
2002-12-31$NZ$0.27 B-56.51%
2001-12-31$NZ$0.64 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Amgen
AMGN
NZ$16.62 B-68.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$0.40 B-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$31.46 B-41.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$136.99 B 156.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$77.33 B 44.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$149.12 B 178.76%๐Ÿ‡ซ๐Ÿ‡ท France